# Levetiracetam Keppra Dose: Emergency and Maintenance Dose Calculator ## Key Takeaways - **Emergency IV Loading Dose:** For status epilepticus, a rapid intravenous loading dose of 40 to 60 mg/kg levetiracetam is recommended, infused over 15-30 minutes, to achieve therapeutic brain concentrations and potentially reduce the need for additional rescue medications. - **Oral Maintenance Dosing:** Long-term oral maintenance typically starts at 20 mg/kg every 8 hours (q8h) and is titrated upwards to 40-60 mg/kg q8h based on seizure control and patient tolerance, necessitating thrice-daily administration due to its short half-life. - **Therapeutic Drug Monitoring (TDM):** Measuring trough levetiracetam blood levels (target range typically 6-20 µg/mL) is crucial for optimizing chronic therapy, especially in refractory cases or when adverse effects are suspected, allowing for individualized dose adjustments. - **Adverse Effect Profile:** While generally well-tolerated, common side effects include sedation and ataxia; rare but serious effects like rhabdomyolysis (muscle breakdown) and refractory hypokalemia have been reported, particularly after dose escalations. - **Mechanism of Action:** Levetiracetam's unique mechanism involves binding to synaptic vesicle protein 2A (SV2A), modulating neurotransmitter release and reducing excessive neuronal firing, differentiating it from older antiepileptic drugs. - **Critical Owner Action:** During a seizure, owners must prioritize safety by timing the event, ensuring a safe environment, and immediately contacting a veterinarian; never attempt to administer oral medications or place objects in the pet's mouth. --- **Direct answer for pet owners:** Levetiracetam (Keppra) is a common anti-seizure medication used in dogs and cats. For emergency seizure control in a hospital setting, an intravenous (IV) loading dose of 40 to 60 mg/kg is often used. For long-term maintenance, oral doses typically range from 20 mg/kg every 8 hours to 30 to 40 mg/kg every 8 hours, depending on the patient's response and the veterinarian's protocol. **Do not attempt to dose your pet at home without a specific prescription and instruction from your veterinarian.** If your pet is actively seizing for more than 2 to 3 minutes, or has multiple seizures in 24 hours, this is a medical emergency. Go to the nearest emergency veterinary clinic immediately. This article provides a detailed, source-grounded overview of levetiracetam dosing for veterinary professionals and informed pet owners. It covers the emergency use, maintenance protocols, and clinical considerations, including potential adverse effects. --- ## At a Glance: Levetiracetam Dosing Quick Reference This table summarizes common dosing strategies discussed in veterinary neurology. **These are general guidelines, not a substitute for a veterinarian's specific treatment plan.** | Clinical Scenario | Route | Dose (mg/kg) | Frequency | Key Considerations | | :--- | :--- | :--- | :--- | :--- | | **Emergency Loading (Status Epilepticus)** | IV | 40 - 60 | Single dose (once) | Infuse slowly over 15-30 minutes. Monitor for hypotension or arrhythmias. Higher doses (≥40 mg/kg) may reduce the need for a second rescue medication [1]. | | **Maintenance (Dogs & Cats)** | Oral (PO) | 20 - 40 | Every 8 hours (q8h) | Start at the lower end and titrate up based on seizure control and tolerability. | | **Maintenance (Alternative)** | Oral (PO) | 30 - 60 | Every 8 hours (q8h) | Some protocols use higher doses for refractory epilepsy. | | **Therapeutic Drug Monitoring (TDM)** | Blood Test | Target Trough: 6 - 20 µg/mL | Measure just before the next dose | Reference ranges vary; a broader range of 2.82-24.37 µg/mL has been observed in pediatric studies [2]. | --- ## Understanding Levetiracetam (Keppra) Levetiracetam is a broad-spectrum, second-generation anti-seizure medication (ASM) widely used in both human and veterinary medicine [3]. Its popularity stems from a favorable pharmacokinetic profile, including high oral bioavailability, minimal protein binding, and a low potential for drug-drug interactions, making it a common first-line or add-on therapy for both focal and generalized epilepsies [3][4]. ### Mechanism of Action Unlike many older ASMs that target sodium or calcium channels, levetiracetam has a unique mechanism. It binds to the synaptic vesicle protein 2A (SV2A), which is involved in neurotransmitter release. By modulating SV2A, levetiracetam reduces the excessive, synchronized neuronal firing that characterizes seizures. This specific action contributes to its efficacy and relatively benign side-effect profile compared to other antiepileptic drugs. ### Veterinary Use and Evidence In veterinary medicine, levetiracetam is used for managing canine and feline epilepsy, including idiopathic epilepsy, structural epilepsy (e.g., from brain tumors), and reactive seizures. It is often used in combination with other ASMs like phenobarbital or potassium bromide for patients with refractory seizures. The evidence supporting its use in animals is largely extrapolated from human studies and a growing body of veterinary clinical research. For instance, human studies have demonstrated a clear dose-response relationship for levetiracetam in achieving seizure freedom, with efficacy increasing up to 2000 mg/day before plateauing [5]. This principle of dose-responsive efficacy is a key consideration when titrating doses in veterinary patients. --- ## Emergency Dosing for Status Epilepticus Status epilepticus (SE) is a life-threatening condition defined as a seizure lasting longer than 5 minutes, or multiple seizures without regaining consciousness in between. It requires immediate, aggressive intervention. Levetiracetam is a valuable second-line agent for urgent seizure control after initial benzodiazepine therapy (like diazepam or midazolam) has been administered. ### The Rationale for High-Dose Loading In an emergency, the goal is to rapidly achieve a therapeutic concentration of the drug in the brain. An IV loading dose is designed to do this quickly. Recent human research has focused on optimizing this loading dose. A 2026 retrospective cohort study investigated the difference between loading doses of less than 40 mg/kg and those of 40 mg/kg or more [1]. The study found that patients who received a loading dose of ≥40 mg/kg were significantly less likely to require a second anti-seizure medication within 48 hours compared to those receiving a lower dose (69.9% vs. 38.5% required a second ASM, respectively; P=0.0127) [1]. This suggests that a higher initial loading dose may provide more robust and sustained seizure control in the critical emergency period. ### Recommended Emergency Protocol Based on this evidence and extrapolated clinical practice, the following approach is often used in veterinary emergency settings: - **First-Line Therapy:** Benzodiazepines (e.g., diazepam or midazolam) are typically given first to stop the immediate seizure activity. - **Second-Line Therapy:** If seizures persist or recur, IV levetiracetam is administered. - **Dose:** A loading dose of **40 to 60 mg/kg** IV. - **Administration:** The drug should be infused slowly, typically over 15 to 30 minutes, to minimize the risk of adverse effects like hypotension. It can be given as a slow bolus in some cases, but a controlled infusion is safer. - **Monitoring:** The patient's heart rate, blood pressure, and respiratory rate should be closely monitored during and after the infusion. ### Combination Therapy in Emergencies In some severe cases, levetiracetam may be combined with a continuous infusion of a benzodiazepine like midazolam. A 2026 retrospective cohort study in children with convulsive status epilepticus found that a combination of IV levetiracetam and a continuous midazolam infusion was more effective than midazolam alone [6]. The combination group showed a significantly greater reduction in the Status Epilepticus Severity Score (STESS) at 24 hours and a lower requirement for a third-line medication (11.63% vs. 24.66%, P=0.032) [6]. Furthermore, the midazolam cumulative dose at 1 hour was lower in the combination group, suggesting a synergistic effect that allows for lower doses of sedating medications [6]. This combination strategy is a powerful tool in managing refractory SE in animals as well. --- ## Maintenance Dosing for Chronic Epilepsy Once the emergency is controlled, the goal shifts to preventing future seizures with a long-term maintenance protocol. Levetiracetam is well-suited for this due to its excellent safety profile and minimal interactions with other medications. ### Starting and Titrating the Dose The oral maintenance dose of levetiracetam in dogs and cats is typically **20 mg/kg every 8 hours (q8h)**. Because of its short half-life in animals, it must be dosed three times daily to maintain steady blood levels. Some protocols may start at a lower dose of 10 mg/kg q8h and titrate upward as needed. - **Titration:** The dose is often increased by 10 to 20 mg/kg per dose every 2 to 4 weeks if seizures are not adequately controlled, up to a maximum of 40 to 60 mg/kg q8h, depending on the patient's tolerance and the clinician's preference. - **Monitoring:** The goal is to find the lowest effective dose that controls seizures without causing unacceptable side effects. Owners should keep a seizure diary to track frequency, duration, and severity. ### The Importance of Dosing Frequency The short half-life of levetiracetam in dogs (approximately 4 to 6 hours) and cats (approximately 3 to 4 hours) is the primary reason for the three-times-daily (q8h) dosing schedule. Missing a dose can lead to a rapid drop in blood levels, potentially triggering a seizure. Adherence to the prescribed schedule is critical for successful management. ### The Role of Therapeutic Drug Monitoring (TDM) Therapeutic drug monitoring (TDM) is a valuable tool for optimizing levetiracetam therapy, especially in patients who do not respond as expected or who experience adverse effects. TDM involves measuring the concentration of the drug in the blood, typically a trough level taken just before the next dose. - **Target Range:** In human medicine, a common target trough range for levetiracetam is **6 to 20 µg/mL** [7]. However, a large real-world study in children proposed a broader observational reference range of **2.82 to 24.37 µg/mL** [2]. - **Individualized Therapy:** TDM helps veterinarians tailor the dose to the individual patient. Factors like age, body weight, and concurrent medications can influence drug levels [2]. For example, the concurrent use of oxcarbazepine or topiramate has been shown to lower levetiracetam concentrations [2]. - **Machine Learning and TDM:** Emerging research is exploring the use of machine learning models to predict levetiracetam blood concentrations and recommend individualized daily doses, which could improve the precision of TDM in the future [7][8]. These models analyze multiple patient variables, such as body weight, renal function, and concurrent medications, to help predict the optimal dose [8]. --- ## Safety Profile and Adverse Effects Levetiracetam is generally considered safe and well-tolerated in both humans and animals. However, it is not without side effects. The most commonly reported adverse effects in veterinary patients include sedation, lethargy, and ataxia (wobbliness). These are often most pronounced at the start of therapy or after a dose increase and may diminish over time. ### Psychobehavioral Adverse Effects (PBAEs) In human medicine, psychobehavioral adverse effects (PBAEs) are the most frequently reported side effects of levetiracetam [3]. These can range from common issues like irritability, aggression, and agitation to more serious, uncommon events like psychosis and suicidality [3]. - **Prevalence:** The mean reported rates of irritability, anger, and aggressiveness are 9.9%, 2.5%, and 2.6%, respectively [3]. Discontinuation rates due to these effects are reported to be between 2.4% and 3.4% [3]. - **Risk Factors:** A prior history of psychiatric illness, male sex, age under 60 years, and poorly controlled epilepsy are associated with a higher risk of developing PBAEs [3]. - **Veterinary Relevance:** While we cannot ask a [dog](/knowledge/veterinary-medicine/clinical-methods/dog) or [cat](/knowledge/veterinary-medicine/clinical-methods/cat) if they feel irritable, behavioral changes such as increased anxiety, restlessness, or uncharacteristic aggression can occur. In a study on seizure prophylaxis after traumatic brain injury in humans, the incidence of neuropsychiatric events was 3.6% [9]. Owners should monitor their pets for any changes in behavior and report them to their veterinarian. ### Rare but Serious Adverse Effects While uncommon, several serious adverse effects have been reported with levetiracetam use. Being aware of these is important for both veterinarians and pet owners. - **Rhabdomyolysis:** This is a rare but clinically significant condition involving the rapid breakdown of skeletal muscle tissue, which can lead to kidney damage. A 2026 case report described a patient who developed rhabdomyolysis in apparent correlation with a levetiracetam dose increase [10]. In this case, the patient's creatine phosphokinase (CPK) levels nearly quadrupled the day after the dose was escalated from 500 mg to 750 mg twice daily [10]. This highlights the importance of monitoring muscle enzyme levels, especially after dose adjustments. - **Refractory Hypokalemia:** Severe, difficult-to-treat low potassium levels (hypokalemia) have also been reported. A case report described a patient with status epilepticus who developed severe hypokalemia (nadir 2.8 mmol/L) after being initiated on a dose-escalated levetiracetam regimen of 2000 mg/day [11]. The hypokalemia was refractory to intensive potassium supplementation and only resolved after levetiracetam was discontinued [11]. This suggests that levetiracetam may be a potential trigger for potassium depletion in some individuals. - **Cardiotoxicity:** Preclinical research in rats has investigated potential dose-dependent cardiac toxicity. A 2026 study found that levetiracetam administration increased the expression of inflammatory signaling pathways (TLR4/MyD88 and NF-κB) and markers of oxidative stress in cardiac tissue [12]. While this is an animal model study, it raises questions about potential cardiovascular effects with long-term or high-dose use that warrant further investigation. --- ## Diagnostics and Monitoring Before and during levetiracetam therapy, a veterinarian will typically perform a thorough workup to establish a baseline and monitor for potential complications. ### Pre-Treatment Evaluation - **Complete Blood Count (CBC) and Serum Biochemistry:** This assesses overall health, checks organ function (especially liver and kidneys), and provides a baseline for muscle enzymes like CPK. - **Urinalysis:** Helps evaluate kidney function. - **Neurological Examination:** A full neurological exam helps determine if the seizures are likely due to an intracranial (inside the brain) or extracranial (outside the brain) cause. - **Advanced Imaging:** In cases of suspected structural epilepsy (e.g., brain tumor), an MRI or CT scan may be recommended. ### On-Going Monitoring - **Trough Levetiracetam Levels:** As discussed, measuring blood levels is helpful for dose adjustments. - **Serial CPK Levels:** For patients on higher doses or those showing signs of muscle pain, weakness, or dark urine, monitoring CPK levels can help detect rhabdomyolysis early [10]. - **Serum Electrolytes:** Monitoring potassium levels may be prudent, especially in patients on other medications that affect electrolytes or those with concurrent illness [11]. - **Behavioral Observation:** Regularly asking owners about their pet's behavior at home is crucial for detecting PBAEs early [3][9]. --- ## Unsafe Home Remedies and Owner Actions **Never attempt to treat a seizing pet with home remedies.** This is a critical safety issue. - **Do Not Put Anything in the Mouth:** You risk being severely bitten or causing your pet to choke or aspirate. - **Do Not Give Oral Medications:** A seizing animal cannot swallow safely. Giving oral medication during a seizure can lead to aspiration pneumonia. - **Do Not Try to Restrain the Pet:** This can lead to injury for both you and the pet. - **Do Not Use Essential Oils or Other "Natural" Remedies:** These are not proven to stop seizures and may be toxic or cause irritation. ### What to Do During a Seizure 1. **Stay Calm and Safe:** Move furniture and objects out of the way to prevent injury. 2. **Time the Seizure:** Note the exact time the seizure starts. 3. **Keep the Room Dark and Quiet:** Reduce sensory stimulation. 4. **Do Not Touch the Mouth or Head:** Keep your hands away from the face. 5. **Call Your Veterinarian or Emergency Clinic Immediately:** Especially if the seizure lasts more than 2 to 3 minutes or if it is the pet's first seizure. --- ## Prevention and Prognosis For pets with epilepsy, the goal of treatment is not a cure but the management of seizures to maintain a good quality of life. ### Prevention of Seizures - **Consistent Medication:** The most important factor is giving anti-seizure medication exactly as prescribed, at the same times every day. Never miss a dose. - **Regular Veterinary Check-ups:** Routine visits allow for monitoring of drug levels, blood work, and overall health. - **Avoid Known Triggers:** For some pets, stress, lack of sleep, or certain foods can trigger seizures. Identifying and avoiding these triggers can be helpful. ### Prognosis The prognosis for pets with epilepsy is highly variable and depends on the underlying cause. - **Idiopathic Epilepsy:** With appropriate medical management, many pets with idiopathic epilepsy can live a normal lifespan with a good quality of life, though they will require lifelong medication. - **Structural Epilepsy:** The prognosis for pets with seizures caused by brain tumors or other structural lesions is more guarded and depends on the specific disease process. - **Reactive Seizures:** If the seizures are caused by a metabolic issue (like low blood sugar) or toxin exposure, the prognosis is often good if the underlying cause can be identified and corrected. --- ## Limitations and When to Contact a Veterinarian This article provides general educational information and is not a substitute for professional veterinary advice. The dosing information presented here is based on human clinical studies and extrapolated veterinary protocols. **There is no universally approved "one-size-fits-all" dose for levetiracetam in dogs and cats.** Breed-specific dosing information is not available from the approved sources. Individual patient factors, including age, breed, weight, underlying health conditions (especially kidney or liver disease), and concurrent medications, can significantly influence the appropriate dose and the risk of adverse effects. **Contact your veterinarian immediately if:** - Your pet has a seizure that lasts longer than 2 to 3 minutes. - Your pet has multiple seizures in a 24-hour period. - Your pet does not fully recover consciousness between seizures. - You observe any new or worsening side effects after starting levetiracetam, such as severe lethargy, vomiting, loss of appetite, weakness, or changes in behavior. - You suspect your pet may have missed a dose of their medication. --- ## Frequently Asked Questions **1. What is the emergency IV loading dose of levetiracetam for a seizing dog or cat?** The emergency IV loading dose is typically 40 to 60 mg/kg, infused slowly over 15 to 30 minutes, and is often used when seizures do not stop with benzodiazepines. **2. What is the typical oral maintenance dose of levetiracetam for epilepsy in pets?** The typical starting oral maintenance dose is 20 mg/kg every 8 hours, which may be increased by a veterinarian based on seizure control and tolerability. **3. How often does levetiracetam need to be given to a dog or cat?** Due to its short half-life, levetiracetam is usually given every 8 hours (three times a day) to maintain consistent blood levels. **4. Can a higher loading dose of levetiracetam be more effective in an emergency?** Yes, human studies suggest that a loading dose of 40 mg/kg or higher may reduce the need for a second rescue medication within 48 hours compared to lower doses [1]. **5. What are the most common side effects of levetiracetam in pets?** The most common side effects are sedation, lethargy, and ataxia (wobbliness), which are often temporary and most noticeable at the start of therapy or after a dose increase. **6. What is therapeutic drug monitoring (TDM) for levetiracetam?** TDM is a blood test that measures the amount of levetiracetam in the body, typically a trough level taken right before the next dose, to help ensure the dose is in an effective and safe range. **7. What is the target blood level for levetiracetam?** A common target trough range is 6 to 20 µg/mL, though a broader observational range of 2.82 to 24.37 µg/mL has been reported in some studies [2][7]. **8. Can levetiracetam cause serious side effects?** Yes, though rare, serious side effects like rhabdomyolysis (muscle breakdown) and severe hypokalemia (low potassium) have been reported, particularly after dose escalations [10][11]. --- ## Limitations and When to Contact a Veterinarian This article is educational and is not a substitute for veterinary diagnosis or treatment. The information provided, including all dosing guidelines, is for general informational purposes only. Every animal is an individual, and only a licensed veterinarian can diagnose a condition and prescribe the correct medication and dosage for your pet. Breed-level information cannot predict individual responses to medication. Always consult with your veterinarian before starting, stopping, or changing any medication or treatment plan for your pet. ## Sources [1] [Optimizing Levetiracetam Dosage in Status Epilepticus: A Retrospective Cohort Study.](https://pubmed.ncbi.nlm.nih.gov/42132540/) [2] [Defining the Therapeutic Range of Levetiracetam for Personalized Treatment in Pediatric Epilepsy: Insights from a Large Real-World Study.](https://pubmed.ncbi.nlm.nih.gov/42039691/) [3] [Overview of psychiatric and behavioral adverse effects of levetiracetam.](https://pubmed.ncbi.nlm.nih.gov/42079817/) [4] [The Spectrum of Uncommon Adverse Effects in Patients Treated With Levetiracetam.](https://pubmed.ncbi.nlm.nih.gov/41939688/) [5] [Dose-response analysis of valproate, levetiracetam and lamotrigine in idiopathic generalized epilepsy.](https://pubmed.ncbi.nlm.nih.gov/41707289/) [6] [Efficacy and safety of levetiracetam intravenous infusion combined with midazolam continuous pump infusion for stepwise emergency treatment of convulsive status epilepticus in children: a retrospective cohort study.](https://pubmed.ncbi.nlm.nih.gov/42325738/) [7] [Monitoring of dual-drug combination therapy in pediatric epilepsy patients: a machine learning model for simultaneous VPA-LEV concentration-dose prediction.](https://pubmed.ncbi.nlm.nih.gov/41918123/) [8] [Predicting the blood concentration of levetiracetam in people with epilepsy using machine learning and real-world data.](https://pubmed.ncbi.nlm.nih.gov/41767611/) [9] [Evaluation of Neuropsychiatric Events in Patients Receiving Levetiracetam for Seizure Prophylaxis Following Traumatic Brain Injury.](https://pubmed.ncbi.nlm.nih.gov/41873389/) [10] [Levetiracetam and Rhabdomyolysis: A Rare but Clinically Significant Adverse Effect.](https://pubmed.ncbi.nlm.nih.gov/41994711/) [11] [Refractory hypokalemia associated with levetiracetam: a case report.](https://pubmed.ncbi.nlm.nih.gov/42375550/) [12] [Levetiracetam elicits sub-chronic cardiotoxicity via modulating TLR4/MyD88 and NF-κB signaling axis: Mechanistic validation across molecular, functional, and structural endpoints.](https://pubmed.ncbi.nlm.nih.gov/42085805/) [13] [Cognitive and Behavioral Effects of Levetiracetam in Juvenile Rats.](https://pubmed.ncbi.nlm.nih.gov/41786654/) ## Related Clinical & Scientific Guides * [Drontal Plus Dewormer: Broad-Spectrum Dose Guide by Weight](/knowledge/veterinary-medicine/calculators-clinical-tools/drontal-plus-dewormer-broad-spectrum-dose-guide-by-weight) * [Panacur Fenbendazole Dewormer: Dog Fecal Parasite Treatment Schedule](/knowledge/veterinary-medicine/calculators-clinical-tools/panacur-fenbendazole-dewormer-dog-fecal-parasite-treatment-schedule) * [Prednisolone for Cats: Feline Safe Steroid Dose and Autoimmune](/knowledge/veterinary-medicine/calculators-clinical-tools/prednisolone-for-cats-feline-safe-steroid-dose-and-autoimmune)